SG11202003873WA - Population-based medication risk stratification and personalized medication risk score - Google Patents
Population-based medication risk stratification and personalized medication risk scoreInfo
- Publication number
- SG11202003873WA SG11202003873WA SG11202003873WA SG11202003873WA SG11202003873WA SG 11202003873W A SG11202003873W A SG 11202003873WA SG 11202003873W A SG11202003873W A SG 11202003873WA SG 11202003873W A SG11202003873W A SG 11202003873WA SG 11202003873W A SG11202003873W A SG 11202003873WA
- Authority
- SG
- Singapore
- Prior art keywords
- medication risk
- population
- personalized
- stratification
- risk score
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 2
- 239000003814 drug Substances 0.000 title 2
- 238000013517 stratification Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/10—Office automation; Time management
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Business, Economics & Management (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Strategic Management (AREA)
- Human Resources & Organizations (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Marketing (AREA)
- Economics (AREA)
- Entrepreneurship & Innovation (AREA)
- Tourism & Hospitality (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762579328P | 2017-10-31 | 2017-10-31 | |
US201762611975P | 2017-12-29 | 2017-12-29 | |
PCT/US2018/058405 WO2019089725A1 (en) | 2017-10-31 | 2018-10-31 | Population-based medication risk stratification and personalized medication risk score |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202003873WA true SG11202003873WA (en) | 2020-05-28 |
Family
ID=66333604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202003873WA SG11202003873WA (en) | 2017-10-31 | 2018-10-31 | Population-based medication risk stratification and personalized medication risk score |
Country Status (5)
Country | Link |
---|---|
US (2) | US20210375486A1 (en) |
EP (1) | EP3704661A4 (en) |
CA (1) | CA3080478A1 (en) |
SG (1) | SG11202003873WA (en) |
WO (1) | WO2019089725A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021016477A1 (en) * | 2019-07-24 | 2021-01-28 | Valisure Llc | Evaluation of safety risks |
US11694810B2 (en) * | 2020-02-12 | 2023-07-04 | MDI Health Technologies Ltd | Systems and methods for computing risk of predicted medical outcomes in patients treated with multiple medications |
TWI775253B (en) * | 2020-12-24 | 2022-08-21 | 宏碁股份有限公司 | Method for calculating high risk route of administration |
CN114242244A (en) * | 2021-12-21 | 2022-03-25 | 广州海思医疗科技有限公司 | Personalized medicine-taking risk prediction and risk stratification system |
WO2024009281A1 (en) * | 2022-07-07 | 2024-01-11 | Johnson & Johnson Consumer Inc. | Method for improving the real-world skin sensitization impact of formulated products |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007116295A2 (en) * | 2006-04-07 | 2007-10-18 | Kantonsspital Bruderholz | Individual assessment and classification of complex diseases by a data-based clinical disease profile |
US8700430B2 (en) * | 2006-07-17 | 2014-04-15 | Walgreen Co. | Optimization of a medication therapy regimen |
US10095836B2 (en) * | 2006-09-29 | 2018-10-09 | Gearbox Llc | Computational systems for biomedical data |
WO2008060287A1 (en) * | 2006-11-17 | 2008-05-22 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Method for determining risk of elderly patient under medical treatment and related systems |
US20100223068A1 (en) * | 2009-02-27 | 2010-09-02 | Erick Von Schweber | Method And Apparatus For The Unified Evaluation, Presentation and Modification of Healthcare Regimens |
US8513259B2 (en) * | 2009-07-03 | 2013-08-20 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
EP2339488A1 (en) * | 2009-12-22 | 2011-06-29 | Apteekide Infotehnoloogia OÜ | A system for analysis and report of drug interactions |
US8744872B1 (en) * | 2013-01-03 | 2014-06-03 | Aetna, Inc. | System and method for pharmacovigilance |
US10210312B2 (en) * | 2013-02-03 | 2019-02-19 | Youscript Inc. | Systems and methods for quantification and presentation of medical risk arising from unknown factors |
US10720241B2 (en) * | 2013-12-23 | 2020-07-21 | Tabula Rasa Healthcare, Inc. | Medication risk mitigation system and method |
-
2018
- 2018-10-31 EP EP18873693.8A patent/EP3704661A4/en active Pending
- 2018-10-31 WO PCT/US2018/058405 patent/WO2019089725A1/en unknown
- 2018-10-31 SG SG11202003873WA patent/SG11202003873WA/en unknown
- 2018-10-31 CA CA3080478A patent/CA3080478A1/en active Pending
- 2018-10-31 US US16/760,631 patent/US20210375486A1/en active Pending
-
2022
- 2022-06-10 US US17/837,841 patent/US20230019434A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20210375486A1 (en) | 2021-12-02 |
EP3704661A4 (en) | 2021-08-04 |
CA3080478A1 (en) | 2019-05-09 |
WO2019089725A1 (en) | 2019-05-09 |
EP3704661A1 (en) | 2020-09-09 |
US20230019434A1 (en) | 2023-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL290496A (en) | Therapeutic antibodies and their uses | |
HK1256796A1 (en) | Bivalent bromodomain inhibitors and uses thereof | |
IL259530A (en) | Shape changing drug delivery devices and methods | |
GB201519858D0 (en) | Therapeutic combinations comprising anti-CD73 antibodies and uses thereof | |
SG11202003873WA (en) | Population-based medication risk stratification and personalized medication risk score | |
ZA201900209B (en) | Novel natural protein and application thereof | |
HK1252026A1 (en) | Pharmaceutical combination and uses thereof | |
HK1247091A1 (en) | Therapeutic antibodies and uses thereof | |
EP4147246A4 (en) | Population-based medication risk stratification and personalized medication risk score | |
HK1244431A1 (en) | Polyaphrons and palpebral administration thereof | |
LT3299384T (en) | Truncated rotavirus vp4 protein and application thereof | |
IL271073A (en) | B4galt1 variants and uses thereof | |
IL264473A (en) | Gpr156 variants and uses thereof | |
PT3250234T (en) | Recombinant mdv1 and the uses thereof | |
PL3389621T3 (en) | Emulsions containig uv-screens and carnosines | |
ZA201801218B (en) | Medicament and nutritional supplement | |
GB201620702D0 (en) | Placement game | |
GB2542851B (en) | Container section and container comprising two container sections | |
GB201617925D0 (en) | Proteins and uses | |
GB201615812D0 (en) | Insulated render and skytrack | |
GB201522469D0 (en) | Word and arithmetic games | |
AU2015901423A0 (en) | Therapeutic antibodies and uses thereof |